Abstract
Skin pigmentation disorders typically involve an overproduction or uneven distribution of melanin, which results in skin spots. Resveratrol can inhibit tyrosinase, the active enzyme in the synthesis of melanin, but it does not inhibit the synthesis of melanin to an extent that enables its use alone as a skin whitening agent in pharmaceutical formulations, so its use as a coadjuvant in treatment of hyperpigmentation is suggested. Six resveratrol analogs were tested for tyrosinase inhibitory activity in vitro. Among the analogs tested, compound D was the most powerful tyrosinase inhibitor (IC 50 = 28.66 μ g/mL), two times more active than resveratrol (IC 50 = 57.05 μ g/mL), followed by the analogs A, E, B, F and C, respectively. This demonstrated that the hydroxylation at C4' on the phenolic ring was the molecular modification with most importance for the observed activity. © 2012 by the authors; licensee MDPI, Basel, Switzerland.
Author supplied keywords
Cite
CITATION STYLE
Zimmermann Franco, D. C., De Carvalho, G. S. G., Rocha, P. R., Da Silva Teixeira, R., Da Silva, A. D., & Barbosa Raposo, N. R. (2012). Inhibitory effects of resveratrol analogs on mushroom tyrosinase activity. Molecules, 17(10), 11816–11825. https://doi.org/10.3390/molecules171011816
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.